Pankaj Patel

His father supplied the pharmaceutical starting point

Patel's father was one of the founders of Cadila Laboratories in 1952, giving the family an established pharmaceutical business before Pankaj Patel's own leadership career began. Forbes says Patel joined the company in 1976, so his path started inside an existing family enterprise rather than with a new startup. ^[1]

Forbes says Patel took charge in 1995 after the two founding families formally separated their interests. That transition left him responsible for the business that became Zydus, turning inherited family-company ownership into a platform on which he could pursue a new period of expansion. ^[1]

Under Patel, Zydus developed into a broader life-sciences company with international operations and a large research organization. An official executive profile filed with the U.S. Securities and Exchange Commission describes his role in directing global operations and strengthening the group's research and development capabilities. ^[2]

Family control continued as the company scaled

Patel remained chairman while his son Sharvil became managing director in 2017, extending operating responsibility into another generation. The arrangement shows how the family retained strategic control even as Zydus became a much larger listed pharmaceutical company. ^[1]

Zydus revenue, research spending and stock-market value are company-level measures rather than Patel's personal wealth. His fortune reflects the family equity he inherited and controlled, together with the additional value created as the pharmaceutical business expanded under his leadership. ^[1][2]